Neumora is a clinical-stage biopharmaceutical company focused on innovating treatments for brain diseases. We develop a robust pipeline of therapies that target novel mechanisms of action, addressing a variety of prevalent and underserved neurological conditions. Our distinct approach aims to redefine neuroscience drug development and enhance patient quality of life.
